Stada Boosted By Consumer And Specialty Growth
As Generics Business Also Delivers Solid Improvement In 2022
Stada has celebrated “growing faster than the markets in which it operates” after delivering a 2022 performance that saw the firm’s earnings lifted in particular by increases in its consumer healthcare and specialty segments.
